[-2]PROPSA PREDICTS BIOPSY RECLASSIFICATION IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER

被引：0
|
作者：
Tosoian, Jeffrey
Isharwal, Sumit
Feng, Zhaoyong
Makarov, Danil
Landis, Patricia
Veltri, Robert
Trock, Bruce
Epstein, Jonathan
Partin, Alan
Sokoll, Lori
Carter, H. B.
Loeb, Stacy
机构：
来源：
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词：
D O I：
10.1016/j.juro.2011.02.2570
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
2323
引用
收藏
页码：E931 / E932
页数：2
相关论文
共 50 条
  • [21] Evaluation of Apparent Diffusion Coefficient as a Predictor of Grade Reclassification in Men on Active Surveillance for Prostate Cancer
    Huang, Mitchell M.
    Macura, Katarzyna J.
    Landis, Patricia
    Epstein, Jonathan, I
    Gawande, Rakhee
    Carter, H. Ballentine
    Mamawala, Mufaddal
    UROLOGY, 2020, 138 : 84 - 90
  • [22] Prostate Specific Antigen Velocity Risk Count Predicts Biopsy Reclassification for Men with Very Low Risk Prostate Cancer
    Patel, Hiten D.
    Feng, Zhaoyong
    Landis, Patricia
    Trock, Bruce J.
    Epstein, Jonathan I.
    Carter, H. Ballentine
    JOURNAL OF UROLOGY, 2014, 191 (03): : 629 - 637
  • [23] GRADE RECLASSIFICATION IN ACTIVE SURVEILLANCE FOR AFRICAN AMERICAN MEN WITH VERY LOW RISK PROSTATE CANCER
    Simopoulos, Demetrios
    Landis, Patricia
    Epstein, Jonathan
    Carter, H. Ballentine
    Gorin, Michael
    Mamawala, Mufaddal
    JOURNAL OF UROLOGY, 2019, 201 (04): : E700 - E700
  • [24] CHANGE IN SERIAL BIOPSY GLEASON SCORE IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE
    Greene, Kirsten L.
    Cowan, Janet E.
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 177 - 177
  • [25] THE PROGNOSTIC IMPACT OF A NEGATIVE CONFIRMATORY BIOPSY IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Salari, Keyan
    Zlatev, Dimitar
    Kuppermann, David
    Preston, Mark
    Dahl, Douglas
    Efstathiou, Jason
    Blute, Michael
    Zietman, Anthony
    Feldman, Adam
    JOURNAL OF UROLOGY, 2018, 199 (04): : E210 - E210
  • [26] Changes in Prostate Cancer Grade on Serial Biopsy in Men Undergoing Active Surveillance
    Porten, Sima P.
    Whitson, Jared M.
    Cowan, Janet E.
    Cooperberg, Matthew R.
    Shinohara, Katsuto
    Perez, Nannette
    Greene, Kirsten L.
    Meng, Maxwell V.
    Carroll, Peter R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (20) : 2795 - 2800
  • [27] Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance
    Mazzucchelli, Roberta
    Galosi, Andrea Benedetto
    Lopez-Beltran, Antonio
    Scarpelli, Marina
    Cheng, Liang
    Montironi, Rodolfo
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2014, 86 (04) : 314 - 318
  • [28] Utility of Anterior Zone Biopsy in Men Enrolled in Active Surveillance for Prostate Cancer
    Glass, Allison S.
    Pugashetti, Neil B.
    Dall'Era, Marc A.
    Evans, Christopher P.
    Yap, Stanley A.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (01) : 58 - 63
  • [29] Prediction of reclassification at repeat biopsy with PSA and [-2]proPSA doubling time during active surveillance for tow risk prostate cancer: Prospective longitudinal analysis of a Japanese multicenter study cohort.
    Hirama, Hiromi
    Sugimoto, Mikio
    Ito, Kazuto
    Shiraishi, Taizo
    Kakehi, Yoshiyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] Prognostic Significance of a Negative Confirmatory Biopsy on Reclassification Among Men on Active Surveillance
    Ganesan, Vishnu
    Dai, Charles
    Nyame, Yaw A.
    Greene, Daniel J.
    Almassi, Nima
    Hettel, Daniel
    Zabell, Joseph
    Arora, Hans
    Haywood, Samuel
    Crane, Alice
    Reichard, Chad
    Zampini, Anna
    Elshafei, Ahmed
    Stein, Robert J.
    Fareed, Khaled
    Jones, J. Stephen
    Gong, Michael
    Stephenson, Andrew J.
    Klein, Eric A.
    Berglund, Ryan K.
    UROLOGY, 2017, 107 : 184 - 189
12345